Literature DB >> 29484564

Single-Axillary-Incision Endoscopic-Assisted Hybrid Technique for Nipple-Sparing Mastectomy: Technique, Preliminary Results, and Patient-Reported Cosmetic Outcome from Preliminary 50 Procedures.

Hung-Wen Lai1,2,3,4, Shih-Lung Lin5, Shou-Tung Chen6,7,8, Ka-Man Kuok7, Shu-Ling Chen6,8, Ya-Ling Lin6, Dar-Ren Chen6,7,8, Shou-Jen Kuo7,8.   

Abstract

BACKGROUND: A new hybrid technique for single-axillary-incision endoscopic-assisted nipple-sparing mastectomy (E-NSM) was introduced. Preliminary results are reported.
METHODS: Patients who received single-axillary-incision E-NSM from August 2013 to August 2017 were searched from a single institution. Data were analyzed to determine the effectiveness and oncologic safety of single-axillary-incision E-NSM. Patient-oriented cosmetic outcome report was also obtained.
RESULTS: During the study period, a total of 50 E-NSM with single-incision procedures were performed in 41 female patients with breast cancer, including 11 (26.8%) patients with bilateral disease. Their mean age was 45.3 ± 8.4 years. The mean size of tumors encountered during the 50 single-incision E-NSM procedures was 2.3 ± 1.8 (0.1-7.3) cm for invasive tumors and 2.6 ± 1.7 (0.2-5.7) cm for carcinoma in situ lesions. Six (12%) of those tumors were multifocal/multicentric. Lymph node metastasis was found during 12% of the procedures. Forty-five (90%) received immediate breast reconstruction with gel implant. Mean operating time was 244.3 ± 82.8 min. The overall complication rate was 6%, and no total nipple necrosis or implant loss was observed. No locoregional recurrence or distant metastasis was found during mean follow-up of 21.6 months. About 94.4% of patients were satisfied with the postoperative scar location and wound length. All patients who responded would choose the same operation again.
CONCLUSIONS: The proposed single-axillary-incision endoscopic hybrid technique for nipple-sparing mastectomy was a safe procedure with low morbidity and associated with high patient satisfaction.

Entities:  

Mesh:

Year:  2018        PMID: 29484564     DOI: 10.1245/s10434-018-6383-z

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  7 in total

1.  Oncologic Outcome of Endoscopic Assisted Breast Surgery Compared with Conventional Approach in Breast Cancer: An Analysis of 3426 Primary Operable Breast Cancer Patients from Single Institute with and Without Propensity Score Matching.

Authors:  Hung-Wen Lai; Shou-Tung Chen; Chiung-Ying Liao; Chi Wei Mok; Ying-Jen Lin; Dar-Ren Chen; Shou-Jen Kuo
Journal:  Ann Surg Oncol       Date:  2021-05-11       Impact factor: 5.344

Review 2.  Evolution of minimal access breast surgery.

Authors:  Chi Wei Mok; Hung-Wen Lai
Journal:  Gland Surg       Date:  2019-12

3.  Association of Long-term Oncologic Prognosis With Minimal Access Breast Surgery vs Conventional Breast Surgery.

Authors:  Andi Wan; Yan Liang; Li Chen; Shushu Wang; Qiyun Shi; Wenting Yan; Xiaozhen Cao; Ling Zhong; Linjun Fan; Peng Tang; Guozhi Zhang; Siyi Xiong; Cheng Wang; Zhen Zeng; Xiujuan Wu; Jun Jiang; Xiaowei Qi; Yi Zhang
Journal:  JAMA Surg       Date:  2022-10-05       Impact factor: 16.681

4.  Single-port 3-dimensional Videoscope-assisted Endoscopic Nipple-sparing Mastectomy in the Management of Breast Cancer.

Authors:  Hung-Wen Lai; Shou-Tung Chen; Chi Wei Mok; Shih-Lung Lin; Chin-Mei Tai; Dar-Ren Chen; Shou-Jen Kuo
Journal:  Plast Reconstr Surg Glob Open       Date:  2019-08-19

5.  Minimal Access (Endoscopic and Robotic) Breast Surgery in the Surgical Treatment of Early Breast Cancer-Trend and Clinical Outcome From a Single-Surgeon Experience Over 10 Years.

Authors:  Hung-Wen Lai; Shou-Tung Chen; Ying-Jen Lin; Shih-Lung Lin; Ching-Min Lin; Dar-Ren Chen; Shou-Jen Kuo
Journal:  Front Oncol       Date:  2021-11-19       Impact factor: 6.244

Review 6.  Oncoplastic Breast Consortium consensus conference on nipple-sparing mastectomy.

Authors:  Walter P Weber; Martin Haug; Christian Kurzeder; Vesna Bjelic-Radisic; Rupert Koller; Roland Reitsamer; Florian Fitzal; Jorge Biazus; Fabricio Brenelli; Cicero Urban; Régis Resende Paulinelli; Jens-Uwe Blohmer; Jörg Heil; Jürgen Hoffmann; Zoltan Matrai; Giuseppe Catanuto; Viviana Galimberti; Oreste Gentilini; Mitchel Barry; Tal Hadar; Tanir M Allweis; Oded Olsha; Maria João Cardoso; Pedro F Gouveia; Isabel T Rubio; Jana de Boniface; Tor Svensjö; Susanne Bucher; Peter Dubsky; Jian Farhadi; Mathias K Fehr; Ilario Fulco; Ursula Ganz-Blättler; Andreas Günthert; Yves Harder; Nik Hauser; Elisabeth A Kappos; Michael Knauer; Julia Landin; Robert Mechera; Francesco Meani; Giacomo Montagna; Mathilde Ritter; Ramon Saccilotto; Fabienne D Schwab; Daniel Steffens; Christoph Tausch; Jasmin Zeindler; Savas D Soysal; Visnu Lohsiriwat; Tibor Kovacs; Anne Tansley; Lynda Wyld; Laszlo Romics; Mahmoud El-Tamer; Andrea L Pusic; Virgilio Sacchini; Michael Gnant
Journal:  Breast Cancer Res Treat       Date:  2018-09-04       Impact factor: 4.872

7.  In pursuit of a flawless aphrodite: paving the way to scarless oncoplastic breast surgery.

Authors:  Liling Zhu; Shunrong Li; Luyuan Tan; Xiaolan Zhang; Jiannan Wu; Fengxi Su; Kai Chen; Erwei Song
Journal:  Cancer Commun (Lond)       Date:  2019-12-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.